CITA Biomedical, Inc. (DTOX)

[jmhollen]

CITA Biomedical Licenses Innovative Treatments for Alcohol, Cocaine, and Crack Dependence to Major California Medical Center
Freedom Treatment Center Treating Patients Successfully Since Early July

BEVERLY HILLS, Calif., Sept. 17 /PRNewswire-FirstCall/ -- CITA Biomedical, Inc. (OTC Bulletin Board: DTOX) a growing leader in the treatment of addiction dependency, today announced that it has signed a license agreement with Freedom Treatment Center in Southern California. The agreement enables Freedom Treatment Center to provide CITA's Detoxification and NeuroAdaptation (DNA) for Addictions family of treatments. Freedom Treatment Center has been successfully treating patients with DNA for Addictions since early July. The DNA for Addictions treatment family includes DNA for Alcohol, DNA for Alcohol and Cocaine, DNA for Cocaine, and DNA for Crack Cocaine. CITA has patents pending for the family of DNA treatments.

"DNA for Addictions family of treatments is an important option for our patients and community," said Dr. Morris Loffman, neurosurgeon and managing partner of Freedom Treatment Center. "Because this is the only service of its kind in this area, our community now has the most advanced and effective treatment options available to them. More important, the service is provided in a medical center setting and safely administered by Freedom's staff of very experienced doctors."

DNA for Addictions establishes a new treatment regimen in the fight against drug addiction, a disorder that impedes normal neural functioning of the brain and body systems as a whole. Addiction causes cravings, possible brain damage, and can lead to potentially life-threatening withdrawal symptoms. Historically, the disorder of addiction has been treated only through behavioral intervention, but the CITA DNA treatment provides a solution for treating both the physiological and psychological components of this devastating disease.

DNA for Addictions patients experience a less than 25 percent relapse rate, compared to a more than 75 percent relapse rate generally associated other accepted means of treating addiction. The new treatment was also shown to reduce the time, pain, and costs associated with withdrawal, and allowed the patients to return to a productive level of functioning within hours of the treatment's completion.

"We are pleased to be working with Freedom Treatment Center and its highly competent medical staff, to provide the DNA for Addictions family of treatments to their community," said Joseph Dunn, president and CEO of CITA Biomedical. "Treating both the physical and psychological components of addiction are key to DNA for Addictions' success and what sets DNA apart from other treatments. By working together, CITA and Freedom Treatment Center are able to offer high quality, safe, and cost effective addiction treatment services."

About CITA Biomedical, Inc.

CITA Biomedical, Inc., headquartered in Beverly Hills, Calif., focuses on the innovative treatment of addiction. The company holds the U.S. patent for its successful UROD (Ultra Rapid Opiate Detoxification) treatment method. UROD is the only clinically tested and effective treatment method to rapidly detoxify individuals addicted to opiate-based drugs, including heroin within four to six hours with few, if any, withdrawal symptoms. The company recently announced a new family of revolutionary treatments, Detoxification and NeuroAdaptation (DNA) for Addictions. The first treatments from this family treat alcohol, cocaine, and poly-drug addictions. To date CITA has grown its business through internal expansion and now seeks compatible, leading, and complementing technologies and acquisitions to enhance its corporate portfolio. CITA Biomedical, Inc. has two operating divisions CITA Americas, Inc., and AltTPro, Inc. For more information, please visit www.citabio.com .

About Freedom Treatment Center

Freedom Treatment Center is a medical center serving the San Fernando Valley area. The medical center offers a continuum of medical, surgical, and addiction services. The center is located at 16255 Ventura Boulevard, Suite 100, Encino, CA 91436. For more information, call 1-888-400-2482.

UROD is a registered trademark of CITA Biomedical, Inc.

For further information, please contact Investor Relations, Judy Ryon of CITA Biomedical, Inc., [phone], [e-mail]; or Treatment Information, [phone], www.cita1.com

SOURCE CITA Biomedical, Inc.

CONTACT: investors, Judy Ryon of CITA Biomedical, Inc., [phone],
[e-mail]; or Treatment Information, [phone]

Web site: http://www.cita1.com

Web site: http://www.citabio.com

.